l

The content of this website is intended for healthcare professionals only

NICE chief executive to step down

Sir Andrew Dillon will leave at the end of March 2020 after 21 years at the helm

Caroline White

Friday, 23 August 2019

Sir Andrew Dillon will leave at the end of March 2020 after 21 years at the helm.

Sir Andrew Dillon, chief executive of the National Institute for Health and Care Excellence (NICE), has announced that he is to step down at the end of March 2020, after 21 years at the helm.

Sir Andrew, who was appointed in April 1999, has led NICE since its inception.

Commenting on his departure, Sir Andrew said: “It has been a privilege to lead the organisation through its first two decades. NICE has made a significant contribution to improving outcomes for people using the health and care services, and to the efficient use of resources. I feel very proud to be associated with those achievements.”

NICE’s chair, Sir David Haslam, added:The role of chief executive of NICE must be one of the most challenging and potentially controversial in British public life. Sir Andrew has carried out this role for 20 enormously successful years, and everyone who knows him – whether in government, the life sciences industry, or in health and social care – is full of admiration for his calm and skilful leadership.”

He continued: “He was there right at the birth of NICE, and will leave it as an internationally respected, world leading, and hugely influential organisation. That’s quite a legacy...”

ABPI chief executive Mike Thompson echoed this sentiment, saying that Sir Andrew had led NICE with a laser focus on establishing how the latest medicines can benefit patients and the NHS.

“He has played a central role in building the credibility of the organisation, insisting on transparent processes, and a continuous dialogue with all stakeholders, recognising that as the science evolves, NICE needs to evolve too.

"As a result of this leadership, there is a consensus across industry about the central role of NICE in assessing all medicines, ensuring that patients have a right to access the treatments they need.”

He added that Sir Andrew was “hugely respected by all,” and thanked him for his “outstanding achievements at NICE.”

The Board will make arrangements to advertise the post during the autumn.


Picture: Sir Andrew Dillon. Courtesy of NICE.

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470